Transdermal Patches: Global Markets

May 2023| PHM273A| BCC Publishing

Report Highlights

The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Report Includes

  • 122 data tables and 53 additional tables
  • An overview of the global transdermal patches market
  • Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
  • Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.

Report Scope

This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.

Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.

This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.

Frequently Asked Questions (FAQs)

The transdermal patches market is projected to grow from $6.4 billion in 2021 to $8.8 billion in 2027, at a compound annual growth rate (CAGR) of 5.6% during the forecast period.
The key factors driving the growth of Transdermal patches market includes
  • Growing incidence of chronic disease and infectious diseases
  • Emerging Non-opioid Drugs for Pain Management and Hormonal treatment
  • Aging Global Population Developments in Transdermal Patch Design
The Transdermal patches market is segmented based on technology, product, application, design and region.
Single-layer Drug Patch segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes
  • GSK plc
  • Mylan Pharmaceuticals inc.(Viatris)
  • Hisamitsu Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical
  • Endo Pharmaceuticals
  • AbbVie Inc.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $6.4 billion
Market size forecast $8.8 billion
Growth rate CAGR of 5.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered technology, application, design, region, and country
Regions covered North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, France, Germany, U.K., Italy, Spain, China, India, Japan, Australia, Middle East, Africa and South America, GCC Countries, Argentina, and Brazil
Key Market Drivers
  • Aging Global Population
  • Developments in Transdermal Patch Design
  • Increase in Modern Lifestyle and Chronic Diseases
  • Emerging Non-opioid Drugs for Pain
  • Management and Hormonal Treatment
  • Rise in Awareness Programs on Transdermal Patches
Companies studied
  • JOHNSON & JOHNSON SERVICES INC.
  • ABBVIE INC.
  • ALVOGEN
  • ICURE PHARMA INC.
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • PERRIGO CO. PLC
  • PURDUE PHARMA L.P.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • AMNEAL PHARMACEUTICALS INC.
  • SPARSHA PHARMA INTERNATIONAL PVT. LTD.
  • NOVARTIS AG
  • LUYE PHARMA GROUP LTD.
  • LAVIPHARM S. A.
  • BAYER AG
  • BAUSCH HEALTH COMPANIES INC.
  • ENDO PHARMACEUTICALS INC.
  • GSK PLC.
  • VIATRIS INC.
  • GRUNENTHAL GMBH

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Transdermal Patches: Global Markets262Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Overview22Free
Chapter- 4: Market Dynamics14Free
Chapter- 5: Impact of COVID-19 on Pharma Industry6Free
Chapter- 6: Emerging Technology in Transdermal Patches5Free
Chapter- 7: Global Market for Transdermal Patches by Product Type10Free
Chapter- 8: Global Market for Transdermal Patches by Design4Free
Chapter- 9: Global Market for Transdermal Patches by Technology4Free
Chapter- 10: Global Market for Transdermal Patches by Application6Free
Chapter- 11: Global Market for Transdermal Patches by Region134Free
Chapter- 12: Competitive Landscape6Free
Chapter- 13: Company Profiles39Free
Transdermal Patches: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS